Drug intelligence / Profile preview

α-glucosyl hesperidin

Development stage
Preclinical
Lead developer
Nagase Viita
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

α-glucosyl hesperidin is a modified form of the citrus flavonoid hesperidin, produced by enzymatically attaching an α-glucosyl group to the parent molecule. This modification dramatically increases its water solubility (by up to 10,000-fold) and bioavailability compared to native hesperidin[5][6][8]. As a result, α-glucosyl hesperidin exhibits enhanced antioxidant and anti-inflammatory properties. It is explored for potential therapeutic effects in cardiovascular health, type II diabetes, obesity prevention (notably in combination with green tea), wound healing, UV protection, and skin health[1][5][6][8]. The compound is used as an ingredient in functional foods and beverages for its health benefits; it also appears in cosmetics for skin hydration and anti-aging purposes. In pharmaceuticals and dietary supplements, it is valued for its neuroprotective effects and ability to support immune function[1].

Brand names
CitraPeak
Other names
alpha-glycosyl hesperidinAGH8α-GH

Beyond the preview

Go deeper on α-glucosyl hesperidin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on α-glucosyl hesperidin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call